These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

368 related items for PubMed ID: 10490971

  • 1. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts.
    Mandelbrot DA, Furukawa Y, McAdam AJ, Alexander SI, Libby P, Mitchell RN, Sharpe AH.
    J Immunol; 1999 Oct 01; 163(7):3753-7. PubMed ID: 10490971
    [Abstract] [Full Text] [Related]

  • 2. The role of donor and recipient B7-1 (CD80) in allograft rejection.
    Zheng XX, Sayegh MH, Zheng XG, Li Y, Linsley PS, Peach R, Borriello F, Strom TB, Sharpe AH, Turka LA.
    J Immunol; 1997 Aug 01; 159(3):1169-73. PubMed ID: 9233610
    [Abstract] [Full Text] [Related]

  • 3. Opposing roles of CD28:B7 and CTLA-4:B7 pathways in regulating in vivo alloresponses in murine recipients of MHC disparate T cells.
    Blazar BR, Taylor PA, Panoskaltsis-Mortari A, Sharpe AH, Vallera DA.
    J Immunol; 1999 Jun 01; 162(11):6368-77. PubMed ID: 10352249
    [Abstract] [Full Text] [Related]

  • 4. Blocking the CD28-B7 T cell costimulation pathway induces long term cardiac allograft acceptance in the absence of IL-4.
    Lakkis FG, Konieczny BT, Saleem S, Baddoura FK, Linsley PS, Alexander DZ, Lowry RP, Pearson TC, Larsen CP.
    J Immunol; 1997 Mar 01; 158(5):2443-8. PubMed ID: 9036995
    [Abstract] [Full Text] [Related]

  • 5. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance.
    Zhou P, Szot GL, Guo Z, Kim O, He G, Wang J, Grusby MJ, Newell KA, Thistlethwaite JR, Bluestone JA, Alegre ML.
    J Immunol; 2000 Nov 15; 165(10):5580-7. PubMed ID: 11067913
    [Abstract] [Full Text] [Related]

  • 6. Cutting edge: blockade of the CD28/B7 costimulatory pathway inhibits intestinal allograft rejection mediated by CD4+ but not CD8+ T cells.
    Newell KA, He G, Guo Z, Kim O, Szot GL, Rulifson I, Zhou P, Hart J, Thistlethwaite JR, Bluestone JA.
    J Immunol; 1999 Sep 01; 163(5):2358-62. PubMed ID: 10452966
    [Abstract] [Full Text] [Related]

  • 7. The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.
    Judge TA, Wu Z, Zheng XG, Sharpe AH, Sayegh MH, Turka LA.
    J Immunol; 1999 Feb 15; 162(4):1947-51. PubMed ID: 9973463
    [Abstract] [Full Text] [Related]

  • 8. B7-dependent T-cell costimulation in mice lacking CD28 and CTLA4.
    Mandelbrot DA, Oosterwegel MA, Shimizu K, Yamada A, Freeman GJ, Mitchell RN, Sayegh MH, Sharpe AH.
    J Clin Invest; 2001 Apr 15; 107(7):881-7. PubMed ID: 11285307
    [Abstract] [Full Text] [Related]

  • 9. CD28-B7 T cell costimulatory blockade by CTLA4Ig in sensitized rat recipients: induction of transplantation tolerance in association with depressed cell-mediated and humoral immune responses.
    Onodera K, Chandraker A, Schaub M, Stadlbauer TH, Korom S, Peach R, Linsley PS, Sayegh MH, Kupiec-Weglinski JW.
    J Immunol; 1997 Aug 15; 159(4):1711-7. PubMed ID: 9257832
    [Abstract] [Full Text] [Related]

  • 10. CD28-independent costimulation of T cells in alloimmune responses.
    Yamada A, Kishimoto K, Dong VM, Sho M, Salama AD, Anosova NG, Benichou G, Mandelbrot DA, Sharpe AH, Turka LA, Auchincloss H, Sayegh MH.
    J Immunol; 2001 Jul 01; 167(1):140-6. PubMed ID: 11418642
    [Abstract] [Full Text] [Related]

  • 11. CTLA4 signals are required to optimally induce allograft tolerance with combined donor-specific transfusion and anti-CD154 monoclonal antibody treatment.
    Zheng XX, Markees TG, Hancock WW, Li Y, Greiner DL, Li XC, Mordes JP, Sayegh MH, Rossini AA, Strom TB.
    J Immunol; 1999 Apr 15; 162(8):4983-90. PubMed ID: 10202046
    [Abstract] [Full Text] [Related]

  • 12. Cytotoxic T lymphocyte antigen 4 (CTLA4) blockade accelerates the acute rejection of cardiac allografts in CD28-deficient mice: CTLA4 can function independently of CD28.
    Lin H, Rathmell JC, Gray GS, Thompson CB, Leiden JM, Alegre ML.
    J Exp Med; 1998 Jul 06; 188(1):199-204. PubMed ID: 9653096
    [Abstract] [Full Text] [Related]

  • 13. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.
    Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC.
    Nature; 1996 May 30; 381(6581):434-8. PubMed ID: 8632801
    [Abstract] [Full Text] [Related]

  • 14. Ex vivo coating of islet cell allografts with murine CTLA4/Fc promotes graft tolerance.
    Steurer W, Nickerson PW, Steele AW, Steiger J, Zheng XX, Strom TB.
    J Immunol; 1995 Aug 01; 155(3):1165-74. PubMed ID: 7543517
    [Abstract] [Full Text] [Related]

  • 15. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K, Schönbeck U, Mach F, Libby P, Mitchell RN.
    J Immunol; 2000 Sep 15; 165(6):3506-18. PubMed ID: 10975872
    [Abstract] [Full Text] [Related]

  • 16. CD28-B7-mediated T cell costimulation in chronic cardiac allograft rejection: differential role of B7-1 in initiation versus progression of graft arteriosclerosis.
    Kim KS, Denton MD, Chandraker A, Knoflach A, Milord R, Waaga AM, Turka LA, Russell ME, Peach R, Sayegh MH.
    Am J Pathol; 2001 Mar 15; 158(3):977-86. PubMed ID: 11238045
    [Abstract] [Full Text] [Related]

  • 17. Allogenic donor splenocytes pretreated with antisense peptide against B7 prolong cardiac allograft survival.
    Chen J, He Q, Zhang R, Chu Y, Wang Y, Liu Q, Xiong S.
    Clin Exp Immunol; 2004 Nov 15; 138(2):245-50. PubMed ID: 15498033
    [Abstract] [Full Text] [Related]

  • 18. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
    Cai Y, Zhou PJ, Tang XD.
    Chin Med J (Engl); 2004 Aug 15; 117(8):1178-83. PubMed ID: 15361291
    [Abstract] [Full Text] [Related]

  • 19. Role of the CTLA4 pathway in hyporesponsiveness induced by intratracheal delivery of alloantigen.
    Shirasugi N, Akiyama Y, Aramaki O, Shibutani S, Matsumoto K, Bashuda H, Yagita H, Okumura K, Ikeda Y, Niimi M.
    Transplantation; 2003 May 27; 75(10):1636-9. PubMed ID: 12777848
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T, Ueno T, Clarkson MR, Yuan X, Jurewicz MM, Yagita H, Azuma M, Sharpe AH, Auchincloss H, Sayegh MH, Najafian N.
    J Immunol; 2005 Jun 01; 174(11):6648-56. PubMed ID: 15905503
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.